Picture of Genmab A/S logo

GMAB Genmab A/S Cashflow Statement

0.000.00%
dk flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Annual cashflow statement for Genmab A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,8595,9043,9837,0355,637
Depreciation
Non-Cash Items-69609-687-239270
Other Non-Cash Items
Changes in Working Capital-1,603-339-1,316-3,2461,178
Change in Accounts Receivable
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,3266,4332,2283,9127,380
Capital Expenditures-111-307-252-317-376
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1,872-2,044-709-2,444-906
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-1,983-2,351-961-2,761-1,282
Financing Cash Flow Items-247-25-50-88-103
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3,66071-420-789-606
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3,0193,7081,6979364,974